Welcome to BioReagent Hub Hotline:19920083827
产品资料来源于品牌方官网 yeasen.com  |  仅供选型参考,规格与库存以官方最新信息为准
品官方资料 · 来源可溯查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-92502ES
HiActi® Recombinant Human BD-2 重组人BD-2 HiActi® Recombinant Human BD-2 重组人BD-2
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

HiActi® Recombinant Human BD-2 重组人BD-2

Scan for product
抗菌研究免疫学研究
Product no.92502ES Sizes5 options SourceYeasen · Official
Cat. No. 92502ES08
现货 $535.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
92502ES08 5 μg $535.00 现货 Enquire
92502ES50 50 μg $2,885.00 现货 Enquire
92502ES76 500 μg $10,835.00 现货 Enquire
92502ES20 20 μg $1,605.00 现货 Enquire
92502ES60 100 μg $4,585.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No92502ES
Specification高纯度、高活性、低内毒素、高批间一致性
Origin翌圣生物科技(上海)股份有限公司
应用方法 抗菌研究研究BD-2的广谱抗菌活性 免疫学研究研究BD-2连接先天与适应性免疫的作用
适用物种种属 人
检测方法 LAL法 SDS-PAGE HPLC 趋化生物测定
生物特性参数 蛋白类型β-防御素 种属来源人 生物活性描述Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using immature human dendritic cells is in a concentration range of 10-100 ng/ml. 应用直接抗菌,广谱抑制细菌、真菌和病毒;趋化免疫细胞,连接先天与适应性免疫。 产品别称Defensin beta2 Beta-defensin 2 Defensin beta 2 BD-2 Accession登录号O15263
技术参数 纯度> 98% as determined by SDS-PAGE and HPLC. 内毒素水平< 1.0 EU per μg by the LAL method. 分子量Approximately 4.3 kDa. 制剂形式Lyophilized from a 0.2 µm filtered concentrated solution in 20 mM PB pH 7.4 130 mM NaCl. 储存条件-25 ~ -15℃保存,收到货之后有效期1年。复溶后,无菌条件下,2~8℃保存,7天有效期。复溶后,无菌条件下,-85 ~ -65℃保存,3个月有效期。 表达系统E.coli 标签No Tag 外观Lyophilized Powder 复溶方法开盖之前,先离心,以将内容物带到底部。使用无菌蒸馏水或PBS复溶,重新配制至0.1-1.0 mg/mL的浓度,可根据后续实验更进一步稀释;长期储存,建议稀释缓冲液中加入载体蛋白(0.1% BSA);分装为一次实验用量,-80℃冻存,避免反复冻融。 表达序列Gly24-Pro64
实验类型 趋化实验测定生物活性

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top